High-risk genomic features predict extramedullary progression in multiple myeloma with paraskeletal plasmacytomas.
Saved in:
| Title: | High-risk genomic features predict extramedullary progression in multiple myeloma with paraskeletal plasmacytomas. |
|---|---|
| Authors: | Stork M; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Ondrouskova E; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Mayerova J; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Mareckova A; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Porc JP; Central European Institute of Technology Masaryk University Brno Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine Masaryk University and University Hospital Brno Brno Czech Republic., Reigl T; Central European Institute of Technology Masaryk University Brno Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine Masaryk University and University Hospital Brno Brno Czech Republic., Mensikova K; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Sendlerova N; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Boichuk I; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Cieslar J; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Bilcikova M; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Adam Z; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Krejci M; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Sandecka V; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Knechtova Z; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Jelinkova Z; Department of Burns and Plastic Surgery University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Krticka M; Trauma Surgery Department University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Nekuda V; Trauma Surgery Department University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Rohan T; Department of Radiology and Nuclear Medicine University Hospital Brno and Masaryk University Brno Czech Republic., Hrabcakova V; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Janska Vojtkova L; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Borsky M; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Radova L; Central European Institute of Technology Masaryk University Brno Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine Masaryk University and University Hospital Brno Brno Czech Republic., Jarosova M; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic.; Central European Institute of Technology Masaryk University Brno Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine Masaryk University and University Hospital Brno Brno Czech Republic., Pour L; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic., Kotaskova J; Department of Internal Medicine - Hematology and Oncology University Hospital Brno and Faculty of Medicine, Masaryk University Brno Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine Masaryk University and University Hospital Brno Brno Czech Republic. |
| Source: | HemaSphere [Hemasphere] 2026 Jun 17; Vol. 10 (6), pp. e70395. Date of Electronic Publication: 2026 Jun 17 (Print Publication: 2026). |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70395 |
